<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>22981640</identifier>
<setSpec>1695-9531</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Mejías, A</dc:author>
<dc:author>Escosa-García, L</dc:author>
<dc:author>Ramilo, O</dc:author>
<dc:description xml:lang="en">Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are an increasing problem in our country. Daptomycin is a bactericidal antibiotic with activity against CA-MRSA. Experience using high-dose daptomycin is reviewed in three paediatric patients with severe-disseminated CA-MRSA infection with a favourable microbiological and clinical response.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2013 Mar </dc:date>
<dc:title xml:lang="es">Daptomicina a dosis altas en infección diseminada por Staphylococcus aureus resistente a meticilina.</dc:title>
<dc:title xml:lang="en">[High-dose daptomycin use in methicillin-resistant Staphylococcus aureus disseminated infection].</dc:title>
<dc:publisher>Anales de pediatria (Barcelona, Spain : 2003)</dc:publisher>
</metadata>
</record>
</pubmed-document>
